Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01251224 · ClinicalTrials.gov registry record · Phase 3
Mouse Allergen and Asthma Intervention Trial
A Phase 3 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 3
- Development phase
- 361
- Enrollment target
NCT01251224: Completed Phase 3 study, sponsored by Johns Hopkins University.
NCT01251224 is a Phase 3 study that has completed, run by Johns Hopkins University. The registered enrollment target is 361 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01251224, a Phase 3 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 361 participants
- Enrollment target
Study Summary
The MAAIT is a randomized, controlled trial of a home intervention to reduce mouse allergen exposure in mouse allergic children with asthma and mouse allergen exposure. Participants will be randomized to either the Integrated Pest Management (IPM) Group or the Education Group. The IPM Group will receive professional mouse abatement, education, two HEPA filters, allergen-proof mattress and pillow encasements, and targeted cleaning. The Education Group will receive education about IPM at the beginning of the trial and then after completion of the trial, will receive the IPM intervention. Participants will be followed for 12 months.
Interventions
- OTHER Education
- OTHER Integrated Pest Management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 361 participants |
| Start Date | 2010-11 |
| Est. Completion | 2016-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01251224
The ClinicalTrials.gov registry entry for NCT01251224 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 361 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Education is the first listed.
NCT01251224 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01251224 about?
NCT01251224 is a clinical study titled "Mouse Allergen and Asthma Intervention Trial". The MAAIT is a randomized, controlled trial of a home intervention to reduce mouse allergen exposure in mouse allergic children with asthma and mouse allergen exposure. Participants will be randomized to either the Integrated Pest Management (IPM) Group or the Education Group. The IPM Group will rec...
What is the current status of trial NCT01251224?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 361 participants. The study started on 2010-11. Estimated completion is 2016-09.
What interventions are being tested in trial NCT01251224?
The interventions under investigation include: Education (OTHER), Integrated Pest Management (OTHER).
Who is sponsoring clinical trial NCT01251224?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.